TSHA R&D Expenses
Taysha Gene Therapies Inc · R&D Expenses
TSHA R&D Expenses
Latest reported$122.56Mperiod ending
TSHA TTM R&D Expenses ($20.62M → $122.56M)
TTM R&D Expenses
High-resolution chart · PNG
TSHA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 122,557,000 | |
| 104,062,000 | |
| 85,818,000 | |
| 76,490,000 | |
| 65,977,000 | |
| 60,909,000 | |
| 66,001,000 | |
| 63,358,000 | |
| 60,203,000 | |
| 64,921,000 | |
| 56,778,000 | |
| 57,957,000 | |
| 62,940,000 | |
| 66,655,000 | |
| 92,323,000 | |
| 116,380,000 | |
| 139,134,000 | |
| 146,271,000 | |
| 131,943,000 | |
| 106,285,000 | |
| 77,814,000 | |
| 50,233,000 | |
| 31,893,000 | |
| 20,620,000 |